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The Sulfonylurea Drug, Glimepiride, 
Stimulates Glucose Transport, Glucose 
Transporter Translocation, and 
Dephosphorylation In Insulin-Resistant 
Rat Adipocytes In Vitro 
GÜNTER MÜLLER AND SUSANNE WIED 
Sulfonylurea drugs are widely used in the therapy of 
NIDDM. The improvement of glucose tolerance after 
long-term treatment of NIDDM patients with the drug 
can be explained by stimulation of glucose utilization 
in peripheral tissues that are characterized by insulin 
resistance in these patients. We studied whether the 
novel sulfonylurea drug, glimepiride, stimulates 
glucose transport into isolated insulin-resistant rat 
adipocytes. After long-term incubation of the cells in 
primary culture with high concentrations of glucose, 
glutamine, and insulin, stimulation of glucose 
transport by insulin was significantly reduced both 
with respect to maximal responsiveness (65% 
decrease of Vmax) and sensitivity (2.6-fold increase of 
ED 5 0 ) compared with adipocytes cultured in medium 
containing a low concentration of glucose and no 
insulin. This reflects insulin resistance of glucose 
transport. In contrast, both responsiveness and 
sensitivity of glucose transport toward stimulation by 
glimepiride were only marginally reduced in 
insulin-resistant adipocytes (15% decrease of Vmax; 
1.2-fold increase of ED 5 0 ) versus control cells. 
Glimepiride, in combination with glucose and 
glutamine during the primary culture, caused 
desensitization of the glucose transport system toward 
stimulation by insulin, but to a lesser degree than 
insulin itself (50% reduction of Vmax; ninefold increase 
of ED 5 0 ) . Again, the maximal responsiveness and 
sensitivity of glucose transport toward stimulation by 
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glimepiride were only slightly diminished. The 
presence of glimepiride during primary culture did not 
antagonize the induction of insulin resistance of 
glucose transport. The stimulation of glucose transport 
in insulin-resistant adipocytes by glimepiride is caused 
by translocation of glucose transporters from 
low-density microsomes to plasma membranes as 
demonstrated by subcellular fractionation and 
immunoblotting with anti-GLUT1 and anti-GLUT4 
antibodies. Immunoprecipitation of GLUT4 from 3 2 P i -
and [35S]methionine-labeled adipocytes revealed that 
the insulin resistance of GLUT4 translocation is 
accompanied by increased (three- to fourfold) 
phosphorylation of GLUT4 in both low-density 
microsomes and plasma membranes. Short-term 
treatment of desensitized adipocytes with glimepiride 
or insulin reduced GLUT4 phosphorylation by -70 and 
25%, respectively, in both fractions. We conclude that 
glimepiride activates glucose transport by stimulation 
of GLUT1 and GLUT4 translocation in rat adipocytes 
via interference at a site downstream of the putative 
molecular defect in the signaling cascade between the 
insulin receptor and the glucose transport system 
induced by high concentrations of glucose and insulin. 
The molecular site of glimepiride action is related to 
GLUT4 phosphorylation/dephosphorylation, which may 
regulate glucose transporter activity and translocation. 
These in vitro findings implicate an additional mode of 
sulfonylurea action in the improvement of glucose 
tolerance of NIDDM patients. Diabetes 42:1852-67, 
1993 
The hypoglycemic potency of sulfonylurea drugs in the treatment of NIDDM has been attributed primarily to acute stimulation of the rate of insulin secretion. However, after long-term treat-
ment of NIDDM patients with sulfonylurea compounds, 
the plasma insulin levels often return to pretreatment 
levels. This is not accompanied by hyperglycemia in the 
fasted state and loss of the improved glucose tolerance 
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(1,2). Euglycemic clamp studies revealed that sulfonyl-
urea compounds increase insulin-induced glucose utili-
zation in normal rats (3) and NIDDM patients (4,5). These 
observations may be taken as an indication for extrapan-
creatic effects of sulfonylurea drugs. However, because 
of the presence of insulin under these experimental 
conditions it is difficult to determine the reasons for the 
increased glucose clearance rates. The compounds ei-
ther directly stimulate rate-limiting steps of glucose me-
tabolism or enhance their insulin sensitivity or improve 
the overall metabolic situation in peripheral tissues be-
cause of increased insulin and reduced glucose levels. 
In vitro studies are useful to discriminate between these 
possibilities. 
Numerous in vitro studies using normal cells demon-
strated that sulfonylurea drugs directly stimulate glucose 
metabolizing steps, i.e., glycogen synthesis in rat adipo-
cytes (6) and glucose transport in BC3H-1 myocytes 
(7,8), L6 myocytes (9), 3T3-LI adipocytes (10), and 
isolated rat adipocytes (11,12). Furthermore, sulfonyl-
urea drugs enhance the action of exogeneous insulin in 
depancreatized dogs (13) and potentiate the insulin 
stimulation of muscle glycogen synthase in NIDDM pa-
tients (14). The sulfonylurea-induced enhancement of 
insulin action could be mimicked in vitro using adipo-
cytes and hepatocytes from STZ-induced diabetic rats. 
Glyburide potentiated insulin-stimulated but not basal 
glucose transport (15), and tolazamide increased insulin-
sensitive but not basal lipogenesis (16). This suggests 
that in the absence of insulin, sulfonylurea drugs exert no 
direct effect on insulin-resistant peripheral and liver cells. 
However, the insulin-resistant state evolving during the 
pathogenesis of NIDDM is characterized by hyperinsu-
linemia. A large body of experimental evidence points to 
significant differences in the genesis and characteristics 
of insulin resistance induced and accompanied by hypo-
and hyperinsulinemia (17-20). Therefore, the question 
emerged whether sulfonylurea drugs exert direct effects 
on peripheral cells that display insulin resistance induced 
by hyperinsulinemia. Previously, Marshall et al. (21) in-
troduced a model system for the induction of insulin 
resistance in vitro by incubation of fat cells in a diabetic 
(hyperinsulinemic and hyperglycemic) milieu character-
istic for NIDDM (22). After 20 h of primary culture with 
high concentrations of glucose, glutamine, and insulin, 
freshly isolated rat adipocytes exhibited a significantly 
reduced maximal insulin responsiveness and sensitivity 
of the initial glucose transport velocity. This state is 
defined as insulin resistance of glucose transport. 
Herein, we used this method to study whether the novel 
sulfonylurea drug, glimepiride, directly stimulates glu-
cose transport in insulin-resistant rat adipocytes. Glime-
piride was chosen because Geisen (23) showed that in 
dogs this drug had a long-lasting hypoglycemic effect 
without markedly elevated plasma insulin levels, sug-
gesting a very efficient extrapancreatic action. We ob-
served a significant direct stimulation of glucose 
transport and GLUT1 and GLUT4 translocation in insulin-
resistant adipocytes by this drug. We then studied the 
possible mechanism of desensitization of the glucose 
transport system toward insulin and of glucose transport 
stimulation by glimepiride. Phosphorylation of compo-
nents of signal transduction cascades has been impli-
cated as a mechanism of desensitization of diverse 
signaling pathways (24,25). Therefore, we asked whether 
the glucose transporter, a component of the insulin 
signaling cascade, is also a target for phosphorylation 
during induction of insulin resistance of glucose transport 
in primary cultured adipocytes. In fact, we observed 
increased GLUT4 phosphorylation under these condi-
tions. The phosphorylation state of GLUT4 becomes 
reduced by acute glimepiride treatment. The possible 
implications for the therapy of NIDDM with sulfonylurea 
drugs are discussed. 
RESEARCH DESIGN AND METHODS 
Radiochemicals and affinity-purified [ 1 2 5 l ]protein A (30 
mCi/mg), polyclonal and donkey anti-rabbit [ 1 2 5 l ] lgG, 
nitrocellulose sheets Hybond C extra, and scintillation 
cocktail ACSII were bought from Amersham-Buchler 
(Braunschweig, Germany); goat anti-rabbit IgG coupled 
to alkaline phosphatase were provided by Sigma (Dei-
senhofen, Germany); dinonylphthalate oil was from 
Merck (Darmstadt, Germany); reagents for cell culture 
were obtained from Gibco-BRL (Eggenstein-Leopold-
shafen, Germany); collagenase type CLS II was bought 
from Worthington (Freehold, NJ); protein A-Sepharose 
was provided by LKB/Pharmacia (Freiburg, Germany); 
and polyclonal rabbit anti-GLUT4 antibodies raised 
against purified rat GLUT4 were provided by Calbiochem 
(Bad Soden, Taunus, Germany). Peptide anti-GLUT4 
antibodies were obtained from a rabbit injected with a 
peptide corresponding to the COOH-terminal 16 amino 
acids of rat GLUT4 (26) and coupled to keyhole limpet 
hemocyanin, and the rabbit anti-GLUT1 antiserum was 
raised against a peptide corresponding to the COOH-
terminal 12 amino acids of the human GLUT1 sequence 
(27). Both antibodies were affinity-purified. Polyclonal 
anti-rat ß-COP and anti-rat Na +-K +-ATPase (a-subunit) 
antisera from rabbit were gifts from Dr. T. Kreis, Heidel-
berg, and Dr. G.V. Jagow, Frankfurt, Germany, respec-
tively. Semisynthetic human insulin and glimepiride (HOE 
490) were prepared by the Pharma Synthesis Depart-
ment of Hoechst Aktiengesellschaft, Frankfurt; glimepir-
ide was dissolved in 25 mM HEPES/KOH (pH 7.4) at a 2 
mM stock solution made daily. 
Preparation of rat adipocytes. Adipocytes were iso-
lated from epididymal fat pads of 160- to 180-g male 
Wistar rats under sterile conditions as described previ-
ously (28) with the following modifications: Cut tissue 
pieces were incubated for 20 min at 37°C with collage-
nase (1 mg/ml) in KRBB, 25 mM HEPES/KOH (pH 7.4), 
0.1 mM glucose, 1 % wt/vol BSA. The cell suspension was 
filtered through a 100-μηη nylon screen, washed 3 times 
by flotation (accumulation in a thin cell layer on top of the 
medium after centrifugation at 1000 g for 1 min in a 
swing-out rotor) with DMEM lacking D-glucose and con­
taining 20 mM HEPES, 2% FCS, 1% BSA, 50 U/ml 
penicillin, 10 mg/ml streptomycin, and then 2 times with 
HBSS according to Traxinger and Marshall (29). The 
suspension was adjusted to a final titer of 1 χ 10 5 cells/ 
ml. 
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Primary culture. Isolated rat adipocytes were main­
tained in primary culture according to published proce­
dures (29,30) with modifications. Briefly, 10 ml of 
adipocyte suspension (1 χ 10 5 cells/ml) were incubated 
at 37°C in sterile 50-ml polystyrene tubes in HBSS 
containing either 5 mM glucose (glucose medium), 20 
mM glucose plus 16 mM glutamine plus 10 nM insulin 
(glucose/glutamine/insulin medium), 20 mM glucose plus 
16 mM glutamine plus 20 μΜ glimepiride (glucose/ 
glutamine/glimiperide medium), or various combinations 
thereof for different periods of time as indicated in the 
figure legends. Subsequently, the cells were washed 4 
times with 50 ml each of HBSS lacking glucose, glu­
tamine, and insulin. After the last wash, the cells were 
suspended in 2.5 ml of the same medium (final titer 
4 χ 10 5 cells/ml) and further incubated for 30 min at 
37°C. This procedure causes the almost complete deac­
tivation of the adipocyte glucose transport system, which 
had been stimulated by insulin during the primary cul­
ture, to basal values (as demonstrated by almost identi­
cal basal glucose transport activities of cells that have 
been incubated for 20 h with glucose medium, glucose/ 
glutamine/insulin medium, and glucose/glutamine/glimi-
peride medium [Fig. 1]). Each of the different adipocyte 
populations were subjected to the same washing, flota­
tion, and deactivation procedures. Therefore, any reduc­
tions of the cell titer and viability were comparable 
between adipocytes incubated in the different media. 
Labeling of adipocytes with 3 2 P i and [35S]methionine. 
For incubation with 3 2 Pi , the isolated adipocytes were 
suspended in low Pi medium (20 ml per gram of original 
tissue) composed of 1% (wt/vol) BSA in HBSS containing 
0.1 mM sodium phosphate (pH 7.4). Cells (20-ml ali-
quots, 1-1.5 χ 10 6 cells/ml) were incubated with 3 2 P (4 
mCi per aliquot) for 2 h at 37°C to achieve steady-state 
labeling with [32P]orthophosphate before incubation with 
insulin or glimepiride. For incubation with [ 3 5S]methio-
nine, adipocytes (50-ml aliquots, 0.5-0.75 χ 10 6 cells/ 
ml) were incubated with [35S]methionine (0.5 mCi per 
aliquot) for 2 h at 37°C, subsequently washed twice with 
HBSS and suspended in HBSS containing 10 mM unla­
beled methionine before incubation with insulin or glime­
piride. After the end of the incubation, the cells were 
centrifuged (1000 g, 30 s) and the medium aspirated. 
The cells were rinsed in HBSS containing protease and 
phosphatase inhibitors (see below) and finally homoge­
nized at 4°C in 20 mM Tris/HCI (pH 7.4), 1 mM EDTA, 250 
mM sucrose containing 100 mM NaF, 100 μΜ sodium 
orthovanadate, 100 mM sodium pyrophosphate, 200 μΜ 
PMSF, 100 μΜ benzamidine, 20 μg/ml of leupeptin, 
pepstatin, aprotinin, and antipain each (buffer A). The cell 
homogenates were used for subcellular fractionation. 
Subcellular fractionation (according to published 
procedures [31,32] with modifications). Briefly, cells 
from 12 rats were preincubated in HBSS containing 
different combinations of glucose, glutamine, insulin, and 
glimepiride, as indicated in the figure legends, and 
washed 3 times. After the last washing step, the packed 
adipocytes (2 ml) were diluted with 50 ml of buffer A and 
homogenized 10 times in aTeflon-in-glass homogenizer. 
The cell homogenate was centrifuged (1500 g, 5 min, 
Insulin Stimulation 
3-O-Methy lg lucoee Transport [ fmol /sec] 
200 η 
0 0,1 1 10 
Insulin [nM] 
Glimepiride Stimulation 
3-0-Methylgluco8e Transport [ fmol /secj 
ο 5 50 
Glimepiride [μΜ] 
FIG. 1. Stimulation of glucose transport by insulin and glimepiride in 
normal and insulin-resistant adipocytes. Adipocytes were cultured in 
glucose medium ( • ) , glucose/glutamine/insulin medium (+), or 
glucose/glutamine/glimepiride medium (*) for 20 h at 37°C. After full 
deactivation of the glucose transport sys tem, the cel ls were incubated 
with various concentrations of insulin or glimepiride for 20 min at 37°C 
and assayed for 3-O-methylglucose transport. E a c h value represents 
the mean ± S E of 15 measurements with five different cell 
preparations. For simplification of the data presentation for this and 
the following experiments, only one half of the error bar ( ± S E ) is 
shown. The lines indicate the extreme of the S E in either of the two 
directions calculated for each value. 
20°C). The postnuclear supernatant was separated from 
the fat cake, and the pellet fraction (containing adipocyte 
ghosts and cell debris) with a needle. 
For preparation of the total membrane fraction, the 
postnuclear supernatant was centrifuged (250,000 g, 90 
min, 4°C). The pellet was suspended in 50 ml buffer A, 
recentrifuged, and finally suspended in buffer A at 0.5 mg 
protein/ml. 
For preparation of LDM, the postnuclear supernatant 
was sequentially centrifuged (12,000 gt 15 min; 50,000 gt 
30 min; 250,000 gt 90 min). The pellet of the last 
centrifugation was suspended in buffer A, recentrifuged, 
and finally suspended in buffer A at 1 mg protein/ml. 
For preparation of PM, the pellet of the 12,000 g 
centrifugation was suspended in 35 ml of buffer A and 
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recentrifuged (1000 g, 10 min). The supernatant was 
centrifuged (12,000 g} 20 min). The pellet was washed 
once, suspended in 5 ml of buffer A, layered onto a 20-ml 
cushion of 38% (wt/vol) sucrose, 20 mM Tris/HCI (pH 
7.4), 1 mM EDTA, and centrifuged (110,000 gf, 60 min, 
4°C). The membranes at the interface between the two 
layers (1 ml) were removed by suction, diluted with three 
volumes of buffer A, and layered on top of an 8-ml 
cushion of 28% Percoll, 250 mM sucrose, 20 mM Tris/HCi 
(pH 7), 1 mM EDTA. After centrifugation (45,000 g, 30 
min, 4°C), the PMs were withdrawn from the lower third of 
the gradient (1 ml) with a Pasteur pipet, diluted with 10 
•olumes of buffer A, and recentrifgued (250,000 g, 90 
min, 4°C). The pellet was suspended, recentrifuged, and 
finally dissolved in buffer A at 0.5 mg protein/ml. All 
samples were stored at -80°C. 
Control experiments were performed using 5'-nucleoti-
dase and lipoprotein lipase activity as PM markers and 
rotenone-insensitive cytochrome c reductase and glu­
cose-6-phosphatase as microsomal markers (mi­
crosomes derived from endoplasmic reticulum and Golgi 
stacks cofractionate with LDM). They demonstrated that 
the observed alterations in GLUT distribution between 
PMs and LDMs after primary culture with glucose me­
dium, glucose/glutamine/insulin medium, glucose/glu-
tamine/glimepiride medium, or short-term treatment with 
insulin or glimepiride are not attributable to different 
recoveries of PM and microsomal membrane protein or 
variations in cross contamination of the membrane frac­
tions isolated from the differently treated cells (data not 
shown). 
Assay for glucose transport. Basal, insulin-, and glime-
piride-stimulated transport of glucose was measured 
after incubation of 200 μΙ of adipocytes in HBSS (4 χ 10 5 
cells/ml) with different concentrations of insulin and 
glimepiride, respectively, (complete dose-response 
curves) in 15-ml polystyrene tubes for 20 min at 37°C. 
Initial rates of glucose transport were determined by 
addition of 50 μΙ HBSS containing either 100 μΜ 
2-deoxy-D-[1-1 4C]glucose (0.5 μΟί) or 100 μΜ 3-O-meth-
yl-D-[1-1 4C]glucose (0.2 μΟ). After 5-min (deoxyglucose) 
or 30-s (methylglucose) incubation at room temperature, 
the reaction was stopped by addition of cytochalasin Β 
(final concentration 50 μΜ) and immediate separation of 
the cells (200-μΙ aliquots) from the medium by centrifu­
gation through 150 μΙ of dinonylphthalate oil in plastic 
tubes. The tubes were then cut through the oil layer and 
the adipocytes counted for radioactivity in 10 ml of 
scintillation cocktail ACSII. Glucose uptake by diffusion 
and trapping of glucose in the intercellular spaces of the 
packed adipocytes were corrected by performing control 
incubations in which cytochalasin Β was present before 
addition of the labeled glucose. These radioactivity val­
ues were subtracted from the total cell-associated radio­
activity. 
It has been demonstrated previously (33,34) that the 
initial rates of glucose transport can be accurately deter­
mined with both hexose derivatives, thus yielding com­
parable stimulatory factors of deoxyglucose and 
methylglucose transport by insulin. Nevertheless, the key 
findings (alterations of the dose-response curves for 
insulin and glimepiride after primary culture of adipo­
cytes) obtained with 2-deoxyglucose were confirmed 
with 3-O-methylglucose (Fig. 1). The use of this glucose 
derivative excludes any influence of the subsequent 
hexokinase reaction on the transport kinetics. Transport 
of 3-O-methylglucose was assayed over 30 s and thus 
led to underestimation of the V m a x and ED 5 0 values for 
insulin-stimulated transport. Nevertheless, the differ­
ences in the initial transport velocities between 2-de­
oxyglucose and 3-O-methylglucose are rather small, and 
the stimulatory factors for insulin are close to published 
values (34). Moreover, underestimations for glucose 
transport stimulation by glimepiride would not affect the 
main conclusions of this study. 
Calculations of sensitivity and responsiveness toward 
insulin and glimepiride were performed by running com­
plete dose-response curves for insulin (0.03-30 nM) and 
glimepiride (1-200 μΜ). Maximal insulin and glimepiride 
stimulation of glucose transport (V m a x ) was determined at 
10 nM and 50 μΜ, respectively. A decrease of V m a x with 
no change in the sensitivity toward the corresponding 
compound is defined as decreased responsiveness. An 
increase in the concentrations of insulin and glimepiride 
necessary for ED 5 0 of glucose transport with no change 
in the maximal responsiveness is defined as decreased 
sensitivity of the glucose transport system toward insulin 
and glimepiride. In this study, the terms insulin-resistant 
and desensitized adipocytes are used for cells that after 
primary culture display reduced insulin responsiveness 
or sensitivity or both. 
Western blotting of GLUT1 and GLUT4. Proteins were 
precipitated with 5% TCA (30 min on ice, 10,000 gf, 5 min; 
followed by three acetone washes and evaporation), 
dissolved in Laemmli buffer containing 2% mercaptoeth-
anol, heated (95°C, 5 min), separated by SDS-PAGE, and 
transferred electrophoretically to nitrocellulose sheets 
(35). The blots were saturated for 4 h at room tempera­
ture with PBS containing 5% defatted milk powder. After 
addition of anti-GLUT1 (1:200) or anti-GLUT4 (1:1000) 
antiserum, the incubation was continued for 16 h at 4°C. 
Subsequently, the sheets were washed 4 times (30 min 
each) in PBS containing 1% TX-100 and then incubated 
with [ 1 2 5 l ]protein A (0.5 μα/ητιΙ) in PBS containing 5% milk 
powder. After four washes (see above), the blots were 
dried and subjected to autoradiography. Immunoreactiv-
ity was quantitated by cutting rectangular strips, corre­
sponding to the locations of either GLUT1 or GLUT4 on 
the developed films, from the nitrocellulose filters and 
counting the filter strips in a 7-counter. Specific binding 
was determined after subtracting half of the sum of 
background radioactivities present on size-matched 
strips of the filter cut from an area above and below each 
immunoreactive transporter band. 
Immunoprecipitation of radiolabeled GLUT4. PMs, 
LDMs, and cell homogenates from 3 2 Pi - or [3 5S]methio-
nine-labeled adipocytes were solubilized in Laemmli 
buffer (5 min, 95°C) at 0.5 mg protein per ml. Equivalent 
sample volumes (up to 50 μΙ) were diluted with 1 ml of 
buffer A containing 1% TX-100, 150 mM NaCI and 
protease and phosphatase inhibitors, and centrifuged 
(10,000 gt 5 min). The supernatant was incubated with 50 
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μΙ of anti-rat GLUT4 peptide antibodies that had been 
adsorbed to protein A-Sepharose (10 μΙ of a 1:500 
antiserum dilution was incubated with 50 mg protein 
A-Sepharose beads in 0.5 ml of the buffer described 
above for 2 h at 4°C under constant shaking. The beads 
were pelleted by centrifugation, washed twice with buffer, 
and resuspended in 1 ml of buffer). After 1 h at 4°C under 
constant shaking, the beads were collected by centrifu­
gation (10,000 gf, 30 s), washed sequentially with 1 ml 
each of buffer A containing 1 % TX-100/100 mM NaCI and 
0.1% TX-100/50 mM NaCI and 0 .1% TX-100. The final 
pellet with the immunocomplex-containing beads was 
solubilized in 50 μΙ of sample buffer (5 min, 95°C) and 
centrifuged. The supernatant was analyzed by SDS-
PAGE and fluorography. 
Miscellaneous procedures. Western blotting with rabbit 
anti-ß-COP, anti-Na +-K +-ATPase, and anti-GLUT4 (total 
protein) antibodies was performed as described above 
for anti-GLUT4 peptide antibodies but using 1:500, 
1:150, and 1:250 antiserum dilutions, respectively. This 
was followed by decoration of the washed nitrocellulose 
filters with anti-rabbit [ 1 2 5 l ] lgG (0.2 μΟί/ηηΙ) and autora­
diography for ß-COP (36) and Na +-K +-ATPase (37), and 
with anti-rabbit IgG coupled to alkaline phosphatase and 
chemiluminescence assay for GLUT4. SDS-PAGE using 
5% stacking and 15% running gels (38,39), autoradiog-
raphy using Kodak X-OM AT AR films, protein determina-
tion with the amidoblack staining method (40), and 
assays for 5'-nucleotidase, lipoprotein lipase (41), rote-
none-insensitive cytochrome c reductase, and glucose-
6-phosphatase (31,42) were performed according to 
published procedures. 
RESULTS 
Primary culture of rat adipocytes can induce insulin 
resistance of glucose transport. As Marshall et a! 
(21,29) demonstrated previously and as is confirmed in 
this study, primary culture of isolated rat adipocytes in 
the presence of high concentrations of glucose and 
insulin leads to a marked desensitization of the glucose 
transport system. In cells incubated for 20 h in the 
presence of 20 mM glucose, 16 mM glutamine, and 10 
nM insulin (hereafter called insulin-resistant or desensi-
tized cells), both the insulin sensitivity (Fig. λ A: ED 5 0 for 
insulin 1.85 nM in insulin-resistant cells vs. 0.45 nM in 
normal cells) and maximal insulin responsiveness (Fig. 
1/A: 61 fmol/s in insulin-resistant cells vs. 186 fmol/s in 
normal cells) of 3-O-methylglucose transport are de­
creased compared with cells maintained at 5 mM glu­
cose during the same period of time (hereafter called 
normal cells). 
Glimepiride stimulates glucose transport in normal 
and desensitized adipocytes. The sulfonylurea drug, 
glimepiride, stimulates initial 3-O-methylglucose trans­
port velocity in normal rat adipocytes (Fig. 1S) in a 
concentration-dependent manner (ED 5 0 = 16.5 μΜ) up 
to eightfold (75 fmol/s). This comprises - 5 0 % of the 
maximal insulin stimulation. With insulin-resistant cells, 
the dose-response curve for glimepiride stimulation of 
glucose transport is only slightly shifted to the right 
Insulin Sensitivity 
2 -Deoxyg lucose Transpor t E D - 5 0 [Ins. nM] 
0 2 4 6 8 10 12 14 16 18 
Pre- lncubat ion Time (hours) 
Glimepiride Sensitivity 
2-Deoxygluco8e T ranspor t E D - 5 0 [drug μΜ] 
20 22 24 
6 8 10 12 14 16 18 
Pre- lncubat ion Time (hours) 
F IG. 2. Time course of the l o s s of insulin and glimepiride sensitivity 
of glucose transport. Adipocytes were cultured in g lucose medium (+), 
glucose/glutamine/insulin medium ( • ) , or glucose/glutamine/ 
glimepiride medium (*) for var ious periods of time at 37°C. After full 
deactivation of the g lucose transport s y s t e m , the ce l ls were incubated 
with a full range of insulin (1 -30 nM) or glimepiride concentrat ions 
(1-200 μΜ) for 20 min at 37°C and a s s a y e d for 2 -deoxyglucose 
transport. Insulin and glimepiride sensitivity ( E D 5 0 ) of the g lucose 
transport system w a s calculated at the indicated t imes from the insulin 
and glimepiride dose - response c u r v e s for each of the three adipocyte 
populations. E a c h value represents the mean ± S E of 16 
measurements with four different cell preparations. 
(ED 5 0 = 22.5 vs. 16.5 μΜ) with a concomitant 15% 
decrease of the maximal transport velocity. 
The extent of resistance toward insulin or glimepiride is 
dependent on the duration of the primary culture and 
insulin concentration (Figs. 2 -4 ) . The development of 
reduced insulin responsiveness of 2-deoxyglucose 
transport (Fig. 3A \ onset after 2 h) precedes the appear­
ance of decreased insulin sensitivity (Fig. 2A\ onset after 
6 h). After 20 h incubation, both parameters are altered 
most pronouncedly. Similar data were obtained with 
3-O-methylglucose (compare with Fig. 1/A). Primary cul­
ture with 5-100 nM causes a significant reduction of the 
insulin responsiveness of 3-O-methylglucose transport 
(Fig. 4A; ED 5 0 = 4.5 nM for half-maximal loss of respon­
siveness). The maximal effect requires 50 nM insulin. 
Therefore, 20 h primary culture in the presence of 50 nM 
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FIG. 3. T ime c o u r s e of the l o s s of insulin and glimepiride 
r e s p o n s i v e n e s s of g lucose transport. Adipocytes were cultured in 
g lucose medium (+), glucose/glutamine/ insul in medium ( • ) , or 
glucose/glutamine/glimepiride medium (*) for var ious periods of time. 
After full deactivation of the g lucose transport s y s t e m , the cel ls were 
incubated with 10 nM insulin or 20 μ Μ glimepiride for 20 min at 37°C 
and subsequent ly a s s a y e d for 2 -deoxyglucose transport. E a c h value 
represents the mean ± S E of 15 measurements with five different cell 
preparations. 
140 
Insulin and Glimepiride Responsiveness 
3-0 -Methy lg luco8e Transport ( fmol /sec l 
125 
0 1 10 
Insulin [nM] durina Pre- lncubation 
Insulin and Glimepiride Responsiveness 
3-O-Methylg luc08e Transport [ fmol /sec] 
"~i 1—ι—I I I I 
5 50 
Glimepiride [uM] during Pre- lncubation 
F IG. 4. Dependency of the insulin and glimepiride responsiveness of 
g lucose transport on the insulin and glimepiride concentration during 
long-term incubation. Adipocytes were cultured in medium containing 
20 mM glucose plus 16 mM glutamine plus various concentrations of 
insulin or glimepiride for 20 h at 37°C. After full deactivation of the 
glucose transport system, one portion of the cel ls w a s incubated 
directly in the absence (+) or presence of 1.85 nM insulin ( • ) or 20 μ Μ 
glimepiride (*) for 20 min at 37°C and a s s a y e d for 3-O-methylglucose 
transport. E a c h value represents the mean ± S E of six measurements 
with two different cell preparations. 
insulin were chosen for all subsequent experiments. In 
contrast, there is no significant loss of glimepiride re­
sponsiveness (Figs. 3ß and 4A) and sensitivity (Fig. 28) 
during primary culture (Figs. 28 and 38) with any insulin 
concentration (Fig. A A) if one takes into account the 
general loss of glucose transport stimulation by insulin or 
glimepiride during the incubation period. 
Glimepiride can substitute for insulin in desensitizing 
glucose transport in primary cultured adipocytes. It 
has been suggested that the requirement of insulin for 
desensitization of isolated rat adipocytes by high con-
centrations of glucose, glutamine, and insulin is based 
solely on the increased influx of glucose (21). Because 
glimepiride stimulates glucose transport to about half-
maximal insulin levels, we asked whether this sulfonyl-
urea drug also causes insulin resistance of glucose 
transport when present during primary culture. Figure λ A 
shows that glimepiride causes a marked reduction of the 
maximal insulin-stimulated 3-O-methylglucose transport 
velocity (102 fmol/s in insulin-resistant cells vs. 192 fmol/s 
in normal cells) and an increase of the ED 5 0 for insulin 
(1.1 nM in insulin-resistant cells vs. 0.45 nM in normal 
cells). The most pronounced reductions of insulin re­
sponsiveness and sensitivity become evident after incu­
bation for 20 h (Figs. 2A and 3/4). The time course for the 
glimepiride-induced insulin resistance lags - 2 - 4 h be­
hind the insulin effect in both its onset and time to reach 
maximum. Interestingly, as insulin present during primary 
culture causes desensitization of the glucose transport 
toward insulin but not glimepiride, long-term treatment 
with this drug provokes insulin resistance of 3-O-methyl­
glucose transport but only marginally impairs transport 
stimulation by the drug itself (Fig. 18). The detailed 
analysis revealed that glimepiride causes an - 5 0 % 
reduction of the maximal insulin-stimulated 2-deoxyglu-
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TABLE 1 
Effect of glimepiride on the induction of insulin resistance of glucose transport 
3-O-methylglucose transport 
Percentage of maximal response Percentage increase of ED50 Conditions of 
primary 
Insulin Glimepiride Insulin Glimepiride culture 
55.7 ± 6.5 89.4 ± 9.9 252 ± 20.3 110 ± 13.4 Glc/Gln/Gli 
32.9 ± 5.5 83.1 ± 7.8 291 ± 26.7 141 ± 10.2 Glc/Gln/lns 
31.2 ±4 .1 74.3 ±6 .1 314 ± 35.7 149 ± 16.1 Glc/Gln/lns/Gli 
Data are means ± SE of six measurements with different cell preparations. Adipocytes were cultured in glucose/glutamine/ 
glimepiride medium or glucose/glutamine/insulin medium in the absence or presence of 50 μΜ glimepiride (glucose/glutamine/ 
insulin/glimepiride) for 20 h at 37°C. After full deactivation of the glucose transport system, portions of the cells were incubated with 
a full range of concentrations of either insulin (0.02-30 nM) or glimepiride (1-200 μΜ) for 20 min at 37°C and then assayed for 
3-Omethylglucose transport. The maximal initial transport velocities (30 nM insulin or 50 μΜ glimepiride, respectively) and the 
increments of the ED 5 0 values for insulin and glimepiride were calculated for each population of adipocytes as the percentage of 
the corresponding values for cells kept in glucose medium (set at 100%). Glc, glucose; Gin, glutamine; Ins, insulin; Gli, glimepiride. 
cose transport (Fig. 3A) and a 2.9-fold increase of the 
ED 5 0 for insulin (Fig. 2A). The maximal glimepiride-
stimulated glucose transport (Fig. 38) and the ED 5 0 
values for glimepiride (Fig. 28) showed only a very slight 
decrease and increase, respectively, after various peri­
ods of primary culture with glimepiride. Figure 48 shows 
the dependency of the glimepiride-induced insulin resis­
tance on the drug concentration. The concentration re­
quired for half-maximal inhibition is 13.5 μΜ and thus 
closely correlated to the ED 5 0 value for stimulation of 
glucose transport by glimepiride. 
In accordance with the impairment of the insulin-
stimulated glucose transport by long-term insulin and 
glimepiride treatment, the drug does not antagonize the 
desensitization of the glucose transport system toward 
insulin when present during the primary culture together 
with insulin (Table 1). The maximal glucose transport 
velocity, responsiveness, and ED 5 0 values for insulin do 
not differ significantly between insulin-resistant adipo­
cytes cultured in the absence or presence of glimepiride. 
Glimepiride stimulates translocation of GLUT1 and 
GLUT4. Next we were interested in the mechanism of 
glucose transport stimulation by glimepiride in normal 
and insulin-resistant adipocytes and of insulin resistance 
induced by long-term glimepiride treatment. Drug stimu­
lation of glucose transport may be attributable to recruit­
ment of GLUT molecules from LDMs to PMs as has been 
well established for insulin (43,44) and to increased 
synthesis of GLUT. Therefore, we studied whether glime­
piride mimicks the insulin-stimulated increase of cell 
surface expression of GLUT1 and GLUT4 (45). For study­
ing the translocation of GLUT1 and GLUT4, cultured rat 
adipocytes were treated with insulin or glimepiride and 
then fractionated into LDMs and PMs. Their relative purity 
is proved by the enrichment and little mutual cross-
contamination of typical marker proteins for PMs, i.e., 
lipoprotein lipase, 5'-nucleotidase, Na +-K +-ATPase (a-
subunit), and for microsomes (which cofractionate but 
are not identical with LDM), i.e., glucose-6-phos-
phatase, rotenone-insensitive cytochrome c reductase, 
and ß-COP, as revealed by enzymic assays (data not 
shown) and Western blot analysis (Table 2). The latter 
demonstrates —10/5-fold enrichment of Na +-K +-ATPase/ 
ß-COP in the PM and LDM fractions, respectively, and 
vice versa. PM and LDM contain only 2 - 4 % of the total 
ß-COP and Na +-K +-ATPase protein, respectively. The 
number of GLUT molecules in both membrane fractions 
was assessed by Western blotting with specific anti-
GLUT1 and anti-GLUT4 peptide antisera. For evaluation 
of possible effects on gene expression of GLUT1 and 
GLUT4, total cellular membrane fractions, from which 
PMs and LDMs were ultimately derived, were prepared 
and tested for anti-GLUT1 and anti-GLUT4 immunoreac-
tivity. 
Incubation of isolated rat adipocytes with insulin in-
creases the amount of GLUT4 and GLUT1 in isolated PM 
by —5- to 6-fold and 2-fold, respectively (Fig. 5A and ß, 
lanes 3 and 6; Fig. 6A and ß). In contrast, the amount of 
both GLUT isoforms decreases in the LDM fraction {lanes 
2 and 5). This reflects the insulin-induced redistribution of 
GLUT4 and GLUT1 from internal stores to the cell sur-
face. Translocation of GLUT is provoked also by glime-
TABLE 2 
Distribution of marker proteins in adipocyte membranes 
Relative immu- Relative 
noreactivity yield 
(arbitrary units) (%) 
Total 
protein N a + - K + - ß- N a + - K + - β-
Fraction (mg) ATPase COP ATPase COP 
Total membranes 8.04 1 1 100 100 
PM fraction 0.39 9.65 0.76 46.8 3.6 
LDM fraction 1.02 0.25 5.42 2.5 55.3 
Rat adipocytes were fractionated into total membranes, LDM, 
and PM. One hundred micrograms of protein of each fraction 
was separated on SDS-PAGE, transferred to nitrocellulose, and 
immunodecorated with rabbit anti-Na +-K +-ATPase and anti-ß-
COP antibodies. After incubation with [ 1 2 5 l]anti-rabbit IgG, 
antibodies and autoradiography nitrocellulose strips corre-
sponding to the visualized Na +-K +-ATPase and ß-COP protein 
bands were counted for radioactivity in a 7-counter. Correction 
for background binding was done as described for Fig. 6. The 
radioactivity measured for 100 μg total membrane protein was 
set at 1 arbitrary unit (relative immunoreactivity), and the radio­
activity calculated for the total adipocyte membranes was set at 
100% (relative yield). 
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FIG. 5. Effect of primary culture and treatment of adipocytes with insulin and glimepiride on G L U T translocation. Adipocytes were cultured in 
g lucose medium, glucose/glutamine/insulin medium, or glucose/glutamine/glimepiride medium for 20 h at 37°C. After full deactivation of the 
g lucose transport system, the cel ls were incubated in the absence (CON) or presence of 10 nM insulin (INS) or 20 μ Μ glimepiride (GU) for 20 
min at 37°C. Subsequently, the cel ls were homogenized. From one half of the homogenate total membranes were prepared (T). The other half 
w a s fractionated into LDM (L) and PM (P) a s described in METHODS. Equivalent amounts of protein (Γ, 200 μ$; L, 18.4 μ ς ; Ρ, 20.6 μς ; the relative 
subcellular distribution of the protein content did not differ significantly between the three adipocyte populations and after stimulation with 
insulin or glimepiride; data not shown) were separated on S D S - P A G E , and the amount of GLUT1 and G L U T 4 in each fraction w a s determined 
separately by immunoblotting with anti-GLUT1 and anti-GLUT4 antibodies, respectively. Autoradiograms of the immunoblots with anti-GLUT4 (A) 
and anti-GLUT1 antibody (B) subsequently decorated with [ 1 2 5 l ]protein A for a typical experiment repeated three times are shown. 
piride (25 μΜ) with - 5 0 % efficiency compared with 
insulin (Fig. 5A and S, lanes 8 and 9; Fig. 6A and B). This 
explains, at least in part, stimulation of glucose transport 
by the drug. 
Glimepiride-stimulated GLUT translocation is only 
slightly reduced in desensitized adipocytes. Desensi­
tization of the glucose transport system leads to a mark­
edly impaired insulin-stimulated increase of the GLUT4 
and GLUT1 number in the PM and decrease in the LDM 
fraction (Fig. 5>Aand S, lanes 14, 15, 23, and 24; Fig. 6C 
and D). The stimulation factors for GLUT4 and GLUT1 
translocation in insulin-resistant versus normal adipo­
cytes, calculated as the ratio of the amount of immuno-
reactive material (arbitrary units in Fig. 6) in the PM 
fraction in the stimulated and basal state, were dimin-
shed (2.7 and 2.8 vs. 5.4). In contrast, the stimulation 
factors of glimepiride are only slightly diminished in 
insulin-resistant versus normal adipocytes, irrespective 
of whether the resistance has been induced by insulin 
(2.6 vs. 3.3) or glimepiride (3.1 vs. 3.3; Fig. 5A and S, 
lanes 17, 18, 26, and 27; Fig. 6E and F). This correlates 
well with the decreased insulin but almost unaltered 
glimepiride responsiveness and sensitivity of the glucose 
transport in desensitized adipocytes. 
The total number of GLUT4 and GLUT1 determined in 
a total membrane fraction does not change during short-
term incubation with either insulin or glimepiride (Fig. 5, 
lanes 1, 4, and 7; Fig. 6A and B). In contrast, the amount 
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F IG. 6. Quantitation of the immunoblot data of Fig. 5. The radioactive filter strips were sl iced and counted for radioactivity in a -/-counter. The 
amount of G L U T 4 and G L U T 1 , respectively, in total membranes of adipocytes cultured in g lucose medium and in the basal state (without insulin 
and glimepiride stimulation) w a s set at 1.0 arbitrary units. E a c h value represents the mean of four fractionations with different cell preparations. 
A C, E: Anti -GLUT4; 0, D, F : anti-GLUT1; 4 , 0 : g lucose medium; C, D: glucose/glutamine/insulin medium; E, F: glucose/glutamine/glimepiride 
medium. ( H i ) , Basa l ; ( ^ ) , insulin stimulation; ( Π ) , glimepiride stimulation. 
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of GLUT4 and GLUTI is significantly reduced after 
primary culture of the adipocytes with glucose and 
glutamine in the presence of either insulin (Fig. 6C and 
D ) or, to a lesser degree, glimepiride (Fig. 6E and F). 
Subsequent acute challenge of insulin or glimepiride of 
insulin-resistant cells does not affect total GLUT4 and 
GLUT1 protein (Fig. 6C-F). 
Glucosamine is involved in desensitization of glu­
cose transport by insulin and glimepiride. Marshall et 
al. (21) have demonstrated that glucosamine is able to 
substitute for glucose and glutamine in inducing desen­
sitization of the glucose transport system. Therefore, we 
studied whether glimepiride is able to circumvent the 
glucosamine-induced insulin resistance. Figure 7A con­
firms that insulin in combination with glucose plus glu­
tamine, but not with either compound alone, reduces the 
maximal insulin responsiveness but leaves the respon­
siveness toward glimepiride largely unimpaired. Glu­
cosamine, but only in combination with insulin, reduces 
the maximal insulin but not glimepiride responsiveness. 
These observations indicate that glimepiride bypasses 
the desensitization of the glucose transport system at a 
site downstream of the formation of glucosamine from 
glucose and glutamine. 
Next we studied whether glimepiride, like insulin, de­
sensitizes glucose transport via formation of glu­
cosamine. Glimepiride in combination with glucosamine 
present during primary culture causes an -50% reduc­
tion of the maximal insulin responsiveness similar to the 
effect of glucose plus glutamine (Fig. 78). Glimepiride 
combined with either glucose or glutamine alone leads to 
only a slight impairment. Under all conditions of primary 
culture, the maximal loss of glimepiride responsiveness 
does not exceed 20%. The ability of glucosamine to 
induce insulin resistance if present together with insulin 
or glimepiride strongly suggests that both agents use 
similar mechanisms for desensitization of glucose trans­
port that may involve increased formation of hexosamine 
derivatives. 
Desensitization of glucose transport in primary cul­
tured adipocytes is accompanied by increased phos­
phorylation of GLUT4. Finally, we studied whether 
increased phosphorylation of GLUT molecules repre­
sents the molecular mechanism for their desensitization 
toward insulin as may be deduced from some recent 
observations (46,47,47a). Therefore, we investigated the 
phosphorylation state of GLUT4 in rat adipocytes during 
desensitization of the glucose transport system. For this, 
adipocytes were cultured for 20 h with high levels of 
glucose, glutamine, and insulin. Subsequently, the cells 
were incubated in the presence of either 3 2 Pi or [ 3 5S] 
methionine under the same conditions for 2 h to achieve 
steady-state labeling of the cells before short-term treat­
ment with insulin or glimepiride. After immunoprecipita-
tion of solubilized total membranes, LDM and PM 
fractions with anti-GLUT4 antibodies, the [ 3 5S]methio-
nine- and 3 2Pi-labeled GLUT4 molecules were analyzed 
by SDS-PAGE. As can be seen from the fluorograms of 
the gels (Fig. 8), induction of insulin resistance by pri­
mary culture of the adipocytes in glucose/glutamine/ 
insulin medium reduces the total amount of GLUT4 
A 
% of m a x i m a l r e s p o n s i v e n e s s 
120 ι 
Glc*ln*ulln Qln*ln»ulin Qlc*Qin+ln«ulin QlcN GlcN*ln«ulln 
C o n d i t i o n s Dur ing P r i m a r y C u l t u r e 
Β 
% of m a x i m a l r e s p o n s i v e n e s s 
120 ι 
Glc+Gli Gln+GII Glc+Gln+Gli GlcN+Gli GlcN+lns+GII 
C o n d i t i o n s Dur ing P r i m a r y C u l t u r e 
F IG. 7. Effect of glucosamine during primary culture on insulin (A) 
and glimepiride ( β ) respons iveness of g lucose transport. Adipocytes 
were cultured in medium containing various combinations of insulin 
(10 nM), glimepiride (50 μΜ) , g lucose (20 mM), glutamine (16 mM), and 
glucosamine (2 mM) for 20 h at 37°C a s indicated. After full 
deactivation of the g lucose transport system, portions of the cel ls 
were incubated in the presence of 10 nM insulin ( • ) or 50 μΜ 
glimepiride ( ^ ) for 20 min at 3 7 X and subsequently assayed for 
2-deoxyglucose transport. The initial transport velocity of cel ls 
cultured in g lucose medium during the 20-h period was set at 100% of 
maximal respons iveness for insulin ( • ) and glimepiride ( ^ ) 
stimulation, respectively. E a c h value represents the mean ± S E of nine 
measurements with three different cell preparat ions. 
protein synthesized during 2 h (compare Fig. 8A and ß, 
lanes 1, 4, and 7) and impairs the insulin-stimulated 
redistribution of GLUT4 from LDM to PM (compare Fig. 
8A and S, lanes 5 and 6). The quantitative evaluation of 
the data (Fig. 8C and 8D) proves that the subcellular 
distribution of [35S]methionine-labeled and immunopre-
cipitated GLUT4 closely reflects the amount of GLUT4 in 
the LDM and PM fractions as revealed by immunoblotting 
(Fig. 5). Despite the loss of GLUT4 protein in desensi-
tized cells, the total amount of 3 2Pi-labeled GLUT4 in-
creases 2.9-fold in these cells (Fig. 8A and ß, lanes 10, 
13, and 16; 8E and F). Correction for the different 
amounts of immunoprecipitated [35S]methionine-labeled 
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F IG. 8. Effect of primary culture and treatment with insulin and glimepiride of adipocytes on the phosphorylation of GLUT4 . Adipocytes were 
cultured in g lucose medium (normal, A, C, E) and glucose/glutamine/insulin medium (desensitized, B, D, F) containing 0.1 mM sodium phosphate 
for 20 h at 3 7 ° C Subsequently, the incubation was continued with [ 3 5 S]methionine {lanes 1-9) or 3 2 P (lanes 10-18) for 2 h. After full deactivation 
of the glucose transport system, the washed cells were incubated in the absence (Control) or presence of 10 nM insulin and 20 μΜ glimepiride 
for 20 min at 37°C (during the periods of g lucose transport deactivation and subsequent treatment with insulin/glimepiride, the same speci f ic 
activity of 3 2 P i w a s present a s during the initial period of steady-state labeling [lanes 9 -18 ] , and the [ 3 5 S]methionine incorporation w a s c h a s e d by 
the addition of 10 mM unlabeled methionine [lanes 1-9]), and washed and homogenized in the presence of 1 mM sodium phosphate. From one 
half of the homogenate, total membranes (T) were prepared. The other half was fractionated into LDM and PM a s described in METHODS. 
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GLUT4 results in a 3.0- to 5.3-fold increase in the amount 
of GLUT4 phosphoprotein in total membranes, LDM and 
PM of desensitized versus normal adipocytes (Table 3). 
This suggests that insulin resistance of the adipocyte 
glucose transport in vitro is accompanied by significant 
phosphorylation of GLUT4 in both LDM and PM. 
Glimepiride reduces the phosphorylation state of 
GLUT4 in insulin-resistant adipocytes. Short-term in­
cubation of desensitized adipocytes with both insulin (10 
nM) and glimepiride (20 μΜ) causes a pronounced 
decrease of the GLUT4 phosphorylation state in total 
membranes, LDM and PM (Fig. 8B, lanes 13-18, and 
8F). However, glimepiride is much more effective than 
insulin (Table 3). The ratios in the amount of GLUT4 
phosphoprotein in LDM and PM only slightly differ be­
tween control and insulin treatment. In contrast, glimepir­
ide treatment causes preferential reduction of the GLUT4 
phosphorylation state in LDM versus PM, however, only 
in desensitized cells (Table 3). Acute treatment of normal 
adipocytes (which contain only a modest amount of 
GLUT4 phosphoprotein) with insulin or glimepiride re­
duces GLUT4 phosphorylation to a similar but minor 
extent (Fig. 8A lanes 13-18, and SE). 
In a control experiment (Fig. 9), we tested whether the 
3 2Pi-labeled and immunoprecipitated 43,000-K protein 
is identical to GLUT4. Cell homogenates from ^Pi-la­
beled normal and desensitized adipocytes that have 
been incubated in the absence or presence of insulin 
and glimepiride were immunoprecipitated with a poly­
clonal anti-GLUT4 antibody (raised against the 16 
COOH-terminal amino acids of rat GLUT4) or preimmune 
serum. After SDS-PAGE of the immunoprecipitates, the 
radiolabeled 43,000-M r protein bands, identified by au­
toradiography (Fig. 9, lanes 1-5), were eluted from the 
gel, separated by SDS-PAGE, and assayed for anti-
GLUT4 immunoreactivity by Western blotting with a dif­
ferent polyclonal anti-GLUT4 antibody (raised against 
purified rat GLUT4) and detection of antibody binding by 
a chemiluminescence assay. The X-ray film exposed to 
the nitrocellulose sheet (Fig. 9, lanes 6-10) demonstrates 
the identity of the phosphorylated and (with anti-GLUT4 
antiserum) immunoprecipitated 43,000-/Wr protein (Fig. 9, 
lanes 2 -5 ) with GLUT4 (Fig. 9, lanes 7-10) and thus, 
together with the nonreactivity of the preimmune serum 
(Fig. 9, lanes 1 and 6), the specificity of the immunopre-
cipitation. Furthermore, the experiment confirms that de­
sensitized adipocytes contain less GLUT4 protein than 
normal adipocytes, which is, however, in a more heavily 
phosphorylated state (compare Fig. 9 lanes 2 and 3 with 
lanes 7 and 8). Again, acute glimepiride treatment does 
not affect the total amount of GLUT4 protein but signifi­
cantly reduces the amount of GLUT4 phosphoprotein 
(Fig. 9, lanes 5 and 10). These data suggest that glime­
piride decreases the phosphorylation of GLUT4, espe­
cially in the LDM fraction of desensitized adipocytes, to a 
higher degree than insulin. 
DISCUSSION 
The aim of this study was to elucidate direct effects of 
sulfonylurea drugs on glucose transport in insulin-resis­
tant isolated rat adipocytes. The insulin resistance was 
induced by hyperinsulinemic and hyperglycemic condi­
tions in primary culture. The reduced maximal insulin 
responsiveness and sensitivity of glucose transport in 
these cells may originate from a postinsulin binding and 
coupling defect between the insulin receptor and the 
translocation machinery and synthesis of GLUT mole­
cules, because we observed impaired redistribution of 
GLUT1 and GLUT4 from LDM to PM and a lowered total 
number of GLUT1 and GLUT4. Both reduced transloca­
tion and synthesis of GLUT4 are characteristic features 
for adipose tissue of obese and nonobese NIDDM pa­
tients (48,49). This suggests similar mechanisms of fat 
cell insulin resistance operating in vivo and in vitro. 
Marshall et al. (50) previously described the effect on 
translocation but could not find any effect on the total 
GLUT number. The reason for this discrepancy is not 
clear but may be related to the different methods used for 
the identification of GLUT, specific antibodies in our 
study versus cytochalasin Β binding (50). 
Effects of glimepiride on glucose transport and GLUT 
translocation in adipocytes. In insulin-resistant cells, 
the sulfonylurea drug glimepiride, in the absence of 
insulin, stimulates glucose transport with only slightly 
reduced sensitivity and responsiveness compared with 
normal cells. In fact, a higher maximal initial transport 
velocity is yielded in insulin-resistant cells by glimepiride 
than by insulin (Fig. 4A). The glucose transport stimula­
tion may rely at least in part on the increased expression 
of GLUT1 and GLUT4 at the cell surface in response to 
drug. This is caused by enhanced translocation rather 
than increased synthesis of GLUT1 and GLUT4 in both 
normal and desensitized adipocytes. Thus, this study 
demonstrates, for the first time, stimulation of GLUT 
recruitment from LDM to PM by a sulfonylurea drug in the 
absence of insulin. In addition, these compounds poten­
tiate the insulin-induced redistribution (51). 
The molecular site(s) of glimepiride action in adipo­
cytes. The data suggest that glimepiride interacts with 
the signaling cascade between the insulin receptor and 
the translocation apparatus downstream of the molecular 
defect of glucosamine-induced desensitization. The ob­
servation that glimepiride present during the primary 
culture instead of insulin also leads to insulin resistance 
of the glucose transport provides further evidence for the 
role of increased glucose influx for desensitization. Inter­
estingly, a glycosyl-phosphatidylinositol-specific phos-
pholipase C becomes activated by glimepiride in 
cultured 3T3 adipocytes (41) and in normal and insulin-
resistant isolated rat adipocytes (G.M., S.W., and A. 
Korndorfer, unpublished observations). The observation 
that activation of this phospholipase requires GLUT 
translocation and experimental evidence from other lab-
Equivalent amounts of protein were solubilized and subjected to immunoprecipitation using anti-GLUT4 peptide antibodies adsorbed to protein 
A-Sepharose . The collected and washed immunoprecipitates were analyzed by S D S - P A G E and fluorography. The results of one typical 
experiment repeated 4 times are shown in A and B. The radioactivities contained in the gel bands of four independent experiments were 
determined by a Berthold scanner. The radiolabel of the immunoprecipitated G L U T 4 in total membranes (T) of adipocytes cultured in glucose 
medium and in the basal state was set at 1.0 arbitrary units. E a c h value represents the mean of four fractionations ± S E (C -F ) . 
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TABLE 3 
[ 3 2 P]:[ 3 5 S] ratio of immunoprecipitated GLUT4 in membrane fractions of metabolically labeled normal and desensitized 
adipocytes after control, acute insulin, and glimepiride treatment calculated from Fig. 8 
Normal adipocytes Desensitized adipocytes 
Control Insulin Glimepiride Control Insulin Glimepiride 
Total membrane 
LDM 
PM 
LDM:PM 
1 
1.01 
1.05 
0.95 
0.75 
0.64 
0.80 
0.80 
0.63 
0.62 
0.78 
0.79 
5.27 
5.47 
3.02 
1.81 
4.04 
4.44 
3.26 
1.36 
2.01 
1.52 
2.25 
0.68 
The last line indicates the ratio of GLUT4 phosphoprotein in LDM and PM. 
oratories (52) argue against direct regulation of glucose 
transport via phospholipase C cleavage products (phos-
phoinositolglycan headgroups) and suggest a different 
site of glimepiride action on glucose transport. 
Regulation of GLUT4 phosphorylation by insulin and 
glimepiride. Reports from several laboratories indicate 
that phosphorylation of GLUT4 at serine/threonine resi­
dues by isoproterenol-stimulated PKA (46) or C a 2 + / 
calmodulin-dependent protein kinase (53) or inhibition of 
protein phosphatases 1 and 2 A by okadaic acid 
(47,47a) reduces the insulin-stimulated glucose trans­
port in isolated rat adipocytes. Therefore, one possible 
mechanism for desensitization of the glucose transport 
and GLUT translocation for insulin stimulation may reside 
in an increased phosphorylation state of GLUT4. If this is 
true, activation of glucose transport and GLUT translo­
cation by treatment of desensitized adipocytes with 
glimepiride should be correlated with diminished GLUT4 
phosphorylation. This is exactly what we observed with 
GLUT4 from both LDM and PM of desensitized adipo­
cytes before and after glimepiride treatment. In contrast, 
insulin is less effective in reducing GLUT4 phosphoryla­
tion. Because extensive GLUT4 phosphorylation in insu­
lin-resistant cells can be observed within 2 h, GLUT4 has 
to undergo a rapid phosphorylation/dephosphorylation 
cycle. Its equilibrium is shifted to phosphorylation during 
desensitization and dephosphorylation during short-term 
glimepiride and (to a minor degree) insulin treatment. 
These modifications may be provoked by stimulation of 
GLUT4 protein kinases (i.e., PKA, PKC) during desensi­
tization, which are inhibited by glimepiride (and insulin). 
Alternatively, GLUT4 protein phosphatase(s) may be 
inhibited during desensitization but stimulated by glime­
piride (and insulin). Although kinases/phosphatases act­
ing on GLUT4 in rat adipocytes have not been identified 
unequivocally so far (54,55), we prefer the former possi­
bility for the following reasons. First, it has been shown in 
isolated adipocytes that hyperglycemia- and cate-
cholamine-induced insulin resistance are associated with 
increased PKC and PKA activity, respectively, and de­
creased insulin receptor kinase (56,57) and glucose 
transport activity (58). This may be responsible for the 
downregulation of the insulin signaling cascade. It is 
possible that similar mechanisms operate during primary 
culture of rat adipocytes in the presence of high concen­
trations of insulin and glucose and in NIDDM in the 
presence of high levels of insulin or counterregulatory 
hormones that elevate cAMP levels (59). Second, we 
were able to demonstrate that incubation of rat adipo­
cytes with glimepiride lowers intracellular cAMP levels 
via stimulation of cAMP phosphodiesterase and reduces 
the intrinsic activity of PKA (G.M., S.W., unpublished 
observations). This has been described previously for 
other sulfonylureas in rat hepatocytes and adipocytes 
(60,61). Third, participation of PKA in phosphorylation 
and densensitization of GLUT4 is suggested by in vitro 
phosphorylation experiments of immunoprecipitated 
GLUT4 from normal and desensitized adipocytes with 
[3 2P]ATP and purified PKA from bovine heart (data not 
shown). The significantly reduced cAMP-dependent 
32Pi-incorporation into GLUT4 in desensitized versus 
normal adipocytes indicates that GLUT4 molecules had 
already been phosphorylated at sites recognized by PKA 
during the period of desensitization. 
Regulation of glucose transport in adipocytes by 
GLUT phosphorylation. Interestingly, Begum and Draz-
nin (62) previously reported increased GLUT4 phosphor­
ylation in adipocytes from STZ-induced diabetic rats (62). 
In contrast to normal cells, insulin did not cause GLUT4 
dephosphorylation in diabetic adipocytes. The authors 
presented evidence that the highly phosphorylated 
GLUT4 in the PM of diabetic adipocytes does not interact 
with particulate phosphatases. This provides another 
explanation for the shift in the phosphorylation/dephos-
phorylation equilibrium of GLUT4 in the diabetic state. 
However, whereas the GLUT4 phenotype is very similar 
between their animal model and our in vitro model of 
desensitized fat cells, the molecular mechanisms for 
altered GLUT4 phosphorylation may differ between insu­
lin resistance caused by hypo- and hyperinsulinemia. 
The correlation between the GLUT4 phosphorylation 
state and glucose transport velocity in normal, desensi­
tized, and desensitized and subsequently glimepiride-
treated rat adipocytes strongly argues for regulation of 
glucose transport by phosphorylation. Operation of this 
mechanism during induction of insulin resistance in vitro 
is also suggested by recent studies of Draznin et al. 
(63,64) with isolated rat adipocytes incubated with para­
thyroid hormone (63) or ATP and thapsigargin (64), which 
both increase cytosolic calcium. These conditions lead to 
insulin-resistant glucose transport as well as phosphory­
lation of GLUT4 and reduced insulin-stimulated dephos­
phorylation of GLUT4. These results strengthen the view 
that in diverse cellular models of insulin resistance, 
reduced insulin-stimulated glucose transport is caused 
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FIG. 9. Specificity of the immunoprecipltation of GLUT4 . Adipocytes 
were cultured in glucose (normal) or glucose/glutamine/insulin 
medium (desensitized) for 20 h at 37 C , then labeled with 3 2 P i for 2 h 
at 37°C, and finally incubated in the absence or presence of insulin (10 
nM) and glimepiride (20 μΜ) for 20 min at 37°C a s described for Fig. 8. 
Cell homogenates were prepared and immunoprecipitated with 
preimmune serum {Pre) or anti-GLUT4 antiserum adsorped to protein 
A-$epharose, The collected immunopraGipitates mr§ separated by 
S D S - P A G E and analyzed by autoradiography (lanes 1-5). The protein 
contained in the radiolabeled 43,000-/tf r band w a s electroeluted from 
the sl iced gel strip, subjected to S D S - P A G E , and transferred to 
nitrocellulose filter, which w a s used for immunoblot analysis with a 
different polyclonal rabbit anti-GLUT4 antibody (raised against total rat 
GLUT4) using anti-rabbit IgG coupled to alkaline phosphatase and a 
chemilumlnescence a s s a y for detection of antibody binding {lanes 
6-10) . 
by the loss of insulin's ability to elicit dephosphorylation 
of GLUT4. 
However, the effect of GLUT4 phosphorylation on 
glucose transport may differ between the different in vitro 
models of insulin resistance. The present experimental 
evidence that phosphorylation of GLUT4 and its cellular 
distribution between LDM and PM are regulated in par­
allel, i.e., increased phosphorylation of GLUT4 is corre­
lated with decreased cell surface expression (Fig. 8), 
suggests that phosphorylation of GLUT4 may act as a 
signal for its endocytosis (as shown for IGF-II, [65]) or 
retention in intracellular stores. The observation that 
glimepiride treatment preferentially diminishes the phos­
phorylation state of GLUT4 in LDM (Table 3) favors the 
possibility that phosphorylation of GLUT4 functions as a 
retention signal for the intracellular compartment. Inter­
estingly, isolated PM vesicles containing phosphorylated 
GLUT4 exhibited decreased glucose transport com­
pared with GLUT4 dephosphorylated in response to 
insulin (63). This raises the possibility that the increased 
phosphorylation state of GLUT4 interferes with the insu­
lin-stimulated intrinsic glucose transport activity of 
GLUT4. It remains to be elucidated whether the different 
underlying mechanisms of glucose transport regulation 
by phosphorylation, which are not mutually exclusive, 
depend on the type of insulin resistance induced in vitro 
and are operating in vivo. 
Extrapancreatic effects of sulfonylureas in vitro and 
in vivo. In addition to adipose tissue, prolonged expo­
sure to high glucose has been reported to acutely and 
chronically downregulate the glucose transport system in 
skeletal muscle, which represents the major site for 
insulin-dependent glucose disposal (66). It will be inter­
esting to see in future studies whether glimepiride will 
compensate the lower number of GLUT4 in PM of muscle 
cells in the basal and insulin-stimulated state. The direct 
stimulation of glucose transport in the isolated rat dia­
phragm (67), perfused rat hindlimb (68), and cultured 
muscle cells (7,8) by sulfonylurea drugs suggests similar 
modes of action of these compounds in muscle and 
adipose tissue. 
The stimulation of glucose transport by glimepiride in 
insulin-resistant adipocytes, which persists even after 
long-term treatment, may have important implications for 
the therapy of NIDDM. In contrast to insulin, glimepiride 
partially circumvents downregulation of the cell surface 
GLUT expression by hyperinsulinemia. This feature may 
contribute to the long-lasting blood glucose-lowering 
capacity of this drug (23), even after chronic therapy. The 
physiological significance of the extrapancreatic action 
of glimepiride is not weakened by the low total serum 
levels of glimepiride (200-400 nM at maximum, E. Drae-
gef, unpublished observations). At this concentration, 
small but significant increases of glucose transport and 
GLUT translocation are already observed in vitro. The 
situation may be different when the insulin resistance is 
induced by hypoinsulinemia instead of hyperinsulinemia 
because glucose transport in adipocytes isolated from 
STZ-induced diabetic rats is not stimulated by sulfonyl­
ureas in the absence of insulin (15). Furthermore, these 
drugs have no effect on in vivo insulin action in STZ-
induced diabetic rats under conditions of severe insulin 
deficiency. However, in the case of simultaneous admin­
istration of insulin using the euglycemic clamp proce­
dure, glimepiride potentiates insulin-stimulated glucose 
disposal in peripheral tissues (I. Ohsawa, unpublished 
observations). Possibly, the expression of a component, 
which is involved in mediating the glimepiride signal to 
the translocation machinery, is under control of insulin 
and thus missing in the insulinopenic state. 
Taken together, this study fits into a speculative frame­
work for a unifying theory of sulfonylurea action based on 
their capacity to directly stimulate insulin secretion in 
glucose-insensitive pancreatic ß-cells and GLUT trans-
location in insulin-resistant fat and muscle cells. Both 
events involve regulated exocytosis and fusion of intra-
cellular vesicles, i.e., secretory granules and insulin-
sensitive glucose transporter vesicles budding from 
tubulo-vesicular structures of the trans-Golgi reticulum 
(69,70), respectively, with the PM, which may be con-
trolled by similar mechanisms. Sulfonylurea receptors 
have been described for both rat ß-cells (71) and 
adipocytes (72), but their structural relationship re-
mained unclear. All the other effects of sulfonylurea drugs 
on glucose metabolism and insulin sensitivity observed 
on isolated cells and in vivo may represent secondary 
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events following altered glucose influx and blood glucose 
levels, respectively. In support of this hypothesis, correc­
tion of hyperglycemia with phlorizin has been reported to 
normalize insulin action in diabetic rats (73,74). 
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